GL1X · GenesisL1 explorer

Research workbench

Molecular and structural characterization of the SH3 domain of ahi-1 in regulation of cellular resistance of BCR-abl+ chronic myeloid leukemia cells to tyrosine kinase inhibitors

Analyse Molecular and structural characterization of the SH3 domain of ahi-1 in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ESR
Type
protein
Length
129 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Jouberin
UniProt
Q8N157

Structure

x-ray diffraction · 2 distinct chains · 13% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AJouberinprotein6514% helix, 46% strandQ8N157
BJouberinprotein6413% helix, 47% strandQ8N157

Ligands and binding sites

  • PEG · Di(hydroxyethyl)ether · additive · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

1 interface between chains.

  • A–B · 359 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 4ESR · Molecular and Structural Characterization of the SH3 Domain of AHI-1 in Regulation of… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8N157 · AlphaFold monomer V2.0 prediction for jouberin (Q8N157) · a predicted model of the same protein · chain B against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.